2 Course ECONR
Braintumors oder Tumorlike diseases
Braintumors oder Tumorlike diseases
-
- 1 / 238
-
Lernkarten
PRIMARY CEREBRAL LYMPHOMA and Perfusion
PCL histopathologically demonstrate angiocentric growth with neoplastic cells forming multiple, thick layers around blood vessels.
Tumor cells are found in the perivascular spaces and within the vessel walls, but hypervascularity is not observed.
Differences in tumor vascularity between GBM and Lymphoma may provide discrimination between the lesions.
Lymphomas present relative decrease in rCBV contrary to hypervascular GBMs,
thus perfusion MRI can be useful in differentiating the two tumortypes.
CONCLUSIONS Perfusion TUmors
- DSC is the most commonly used method of MR perfusion
- Increased (>1.75) rCBV correlates with high grade tumor
- Heterogeneous perfusion correlates with high grade tumor
- Meningiomas also have increased rCBV but a hight leakage (T2* not hight after peak
- Lymphoma less vascular than high grade gliomas
- Metastasis pertitumoral rCBV not high
Advantage PRESS
less sensitive to motion and
diffusion
better for intermediate and
long echo-times
Advantage STEAM (Spectro)
less S/N
sensitive to the coupling effects from metabolites
best for short-echo times
better water-suppression
AB welchem Alter ha Spectroskopie
2 Jahre
standard metabolic ratios (Spectro)
NAA/Cr
NAA/Cho
Cho/
Cho/N
normal abnormal
NAA/Cr 2.0 <1.6
NAA/Cho 1.6 <1.2
Cho/Cr 1.2 >1.5
Cho/NAA 0.7 > 1.0
Lac in Spectroscopie when seen (Tumors)?
- inverted doublet at 1.3 – 1.4 ppm on TE 144 ms
• endpoint of anaerobic glycolysis
• it is most often seen in high grade gliomas and metastases (adults)
What does DWI measure
Magnitude of Water diffusion
ADC -> Einheit?
10-3 mm2/s
DTI
What does it measure?
magnitude and direction of Diffusion
shows microstrukture (anisotropie)
Tumor with high cellularitiy
(and high DWI resstrictrion)
Lymphoma
Neurglial tumors
What is Diffusionrestruction with exitotoxic glutamate induced oedema?
DAI
Hypoxic brain dmage
MS
Kreutzfeld jacob
shaken Baby
Hepatic encephalopath
Pontin myelinolysis
Wernicke
Anteile primitive GMB (primär) in %
95%
Sekundäre from Astro II-> IV
Which TUmorfaktor is correltated to CBV
Vascular endothelial growth factor
Does in Ologodenraglioma enhancem mean malignant transformation?
no!
50% of Oligo enhance at Grad II
PS: 40% of anaplastic Astro don't enhance
Gliomarten
Astrocytome
Oligodendrogliome
Ependymome
Plexuscarcinome
MTT Formel (with CBV CBF)
MTT = CBV / CBF
rCBV in lowgradtumor
in high grad Tumor?
>1.5
>1.75
EXTRA-INTRA CEREBRAL:
• EXTRA-INTRA AXIAL:
Difference?
EXTRA-INTRA CEREBRAL:
originating from CNS cells
• EXTRA-INTRA AXIAL:
localized out or into the CNS
Welche Echozeit für Lactt
mittlelere 144 ms
inverted
Welche peaks better in long echotime 288 ms
NAA, Chol , Krea
Which Metabolits besser echotime 35 ms
Lipid, glu/gln, acetat
PEAK
Acetat (Infektion v-ppm?)
NAA?
1.98 Acetate
2 NAA
Abzess spectro in 24h after treatment- else unctable
Anatomische Verbindung wernicke-> Brocca
Fasciculus arcuatus (AF)
Fractionierte Aisotropie DTI
Kann welche Werte annehmen?
0 bis 1
z.B.
Graue Substanz unorganisiert -> 0.1
Corpus callosum 1
periphere weisse Substanz 0.5-0.6
Deoxyhb para- oder diamegentic
paramagnetic
in suszept weighting signalsenkung
oxyhb steigerung -> BOLD-EFFEkt , da oyxhb zu deoxyhb gesteigert (Vasodilatation)
Wenn Läsion in T2 zentral dunkel und randständig ringförmig anreichert DD
Granulomatöse erkr wie TBC, Sarcoid, sonstiger infekt
Tracer PET für Recurrent Tumor in Astrozytoma or Oligodendroglioma (Proliferationsmarker)
18F-fluoro-3'-deoxy-3'-L: -fluorothymidine (18F-FLT) - Proliferationmarker, does not cross the BBB
or
18F-fluoro-dihydroxy-l-phenylalanine (F-DOPA) -> Oligodendroglioma Aminoacid crosses BBB -> better for recurrent Tumor
RANO Criteria tumour progression
• < 12 weeks after chemoradiotherapy
– new enhancement outside of the radiation field
• >12 weeks after chemoradiotherapy
– 25% increase of enhancing area
– New enhancement outside radiation field
– Significant increase of non-enahcing T2/FLAIR lesion on stable or increasing doses of corticosteroids
• Clinical deterioration not result of comorbidities
The “rule of the 90’s” in Kraniophayngeoma
• 90% have calcifications
• 90% are (at least partly) cystic
• 90% enhances
• >90% are suprasellar in location
Most realabe paramter for Tumor recuurence
rCBV > 1.75
Pseudo-progression (what is it?)
– transient increase in contrast enhancement
– in 20–30% of GBMs receiving radiation and temozolomide
– inflammatory reaction ; increased permeability of BBB
-> rCBV can resolve!!
Pseudo-response (what is it?)
– after anti-angiogenic treatment
– rapid decrease of enhancement but minimal effect on overall
survival
– VEGF inhibitors result in rapid normalization of the BBB
APT (Amino proton transvere) MRT
Turnover of Proteins in GBM
Unterscheidung Necrosis from Tumorrecuurence
Adenoma and Cephaleo-> think of
Apolexia Hypophysis -> life threatening
Differentiation Schwanomma and Meniegioma
Schwannoma gradually enhancement
Meneingeioma sudden enhancemnd
TRacer for Paraganglioma in PET
18-FDOPA
Mengieoma Spectroscopie spezifischer Marker
Alanin
Where is Chordoam arising off?
Spenooccipital synochondrosis
Notochordial rests
Is Chondrosarkoma of skullbase midline
no, most always off midline -(vs chordoma)